Parallax Volatility Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,000
| Closed | -$3.39M | – | 1842 |
|
|
2025
Q1 | $3.39M | Sell |
7,000
-500
| -7% | -$233K | 0.01% | 723 |
|
|
2024
Q4 | $3.02M | Buy |
7,500
+300
| +4% | +$139K | 0.01% | 1015 |
|
|
2024
Q3 | $3.35M | Hold |
7,200
| – | – | 0.01% | 955 |
|
|
2024
Q2 | $3.37M | Sell |
7,200
-32,200
| -82% | -$14M | 0.01% | 849 |
|
|
2024
Q1 | $16.5M | Buy |
39,400
+38,800
| +6,467% | +$16.4M | 0.04% | 366 |
|
|
2023
Q4 | $244K | Sell |
600
-10,000
| -94% | -$3.69M | ﹤0.01% | 1742 |
|
|
2023
Q3 | $3.69M | Buy |
10,600
+9,600
| +960% | +$3.36M | 0.01% | 880 |
|
|
2023
Q2 | $352K | Sell |
1,000
-200
| -17% | -$67.4K | ﹤0.01% | 1763 |
|
|
2023
Q1 | $378K | Sell |
1,200
-14,900
| -93% | -$4.47M | ﹤0.01% | 1816 |
|
|
2022
Q4 | $4.65M | Buy |
16,100
+2,000
| +14% | +$610K | 0.01% | 1059 |
|
|
2022
Q3 | $4.08M | Sell |
14,100
-72,300
| -84% | -$20.8M | 0.01% | 1108 |
|
|
2022
Q2 | $24.3M | Sell |
86,400
-336,000
| -80% | -$89.9M | 0.02% | 430 |
|
|
2022
Q1 | $110M | Sell |
422,400
-84,400
| -17% | -$20M | 0.06% | 120 |
|
|
2021
Q4 | $111M | Buy |
506,800
+454,200
| +863% | +$88.3M | 0.13% | 104 |
|
|
2021
Q3 | $9.54M | Sell |
52,600
-13,200
| -20% | -$2.58M | 0.01% | 661 |
|
|
2021
Q2 | $13.3M | Buy |
65,800
+1,800
| +3% | +$377K | 0.02% | 455 |
|
|
2021
Q1 | $13.8M | Buy |
64,000
+30,400
| +90% | +$6.68M | 0.03% | 335 |
|
|
2020
Q4 | $7.94M | Buy |
33,600
+18,700
| +126% | +$4.29M | 0.01% | 797 |
|
|
2020
Q3 | $4.05M | Sell |
14,900
-21,200
| -59% | -$5.85M | ﹤0.01% | 1414 |
|
|
2020
Q2 | $10.5M | Buy |
36,100
+19,300
| +115% | +$5.23M | 0.01% | 765 |
|
|
2020
Q1 | $4M | Hold |
16,800
| – | – | 0.01% | 960 |
|
|
2019
Q4 | $3.68M | Buy |
16,800
+11,300
| +205% | +$2.29M | ﹤0.01% | 1019 |
|
|
2019
Q3 | $933K | Sell |
5,500
-7,500
| -58% | -$1.33M | ﹤0.01% | 1407 |
|
|
2019
Q2 | $2.38M | Buy |
13,000
+9,700
| +294% | +$1.7M | ﹤0.01% | 981 |
|
|
2019
Q1 | $607K | Sell |
3,300
-34,400
| -91% | -$6.35M | ﹤0.01% | 1459 |
|
|
2018
Q4 | $6.25M | Buy |
+37,700
| New | +$6.53M | 0.01% | 659 |
|
|
2017
Q1 | – | Sell |
-25,000
| Closed | -$1.84M | – | 4742 |
|
|
2016
Q4 | $1.84M | Hold |
25,000
| – | – | ﹤0.01% | 1002 |
|
|
2016
Q3 | $2.18M | Buy |
+25,000
| New | +$2.36M | ﹤0.01% | 977 |
|
|
2015
Q4 | – | Sell |
-15,000
| Closed | -$1.56M | – | 4011 |
|
|
2015
Q3 | $1.56M | Buy |
+15,000
| New | +$1.93M | ﹤0.01% | 1124 |
|
Other funds holding VRTX
Parallax Volatility Advisers's VRTX Position: Q3 2025 in Review
Parallax Volatility Advisers sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 1,046 shares — an estimated $466K sold.
Parallax Volatility Advisers first reported a position in VRTX in Q2 2014 and held it in 29 quarters. The position peaked at $8.99M in Q1 2017. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.
- Parallax Volatility Advisers reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
- Parallax Volatility Advisers sold 1,046 Vertex Pharmaceuticals shares in Q3 2025, an estimated $466K.
- Parallax Volatility Advisers first reported a position in Vertex Pharmaceuticals in Q2 2014 and held it in 29 quarters.
- Parallax Volatility Advisers's Vertex Pharmaceuticals position peaked at $8.99M in Q1 2017.
- 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.
Based on Parallax Volatility Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.